BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 37105506)

  • 21. Intracellular Notch1 Signaling in Cancer-Associated Fibroblasts Dictates the Plasticity and Stemness of Melanoma Stem/Initiating Cells.
    Du Y; Shao H; Moller M; Prokupets R; Tse YT; Liu ZJ
    Stem Cells; 2019 Jul; 37(7):865-875. PubMed ID: 30941836
    [TBL] [Abstract][Full Text] [Related]  

  • 22. RNA-binding protein IGF2BP2 enhances circ_0000745 abundancy and promotes aggressiveness and stemness of ovarian cancer cells via the microRNA-3187-3p/ERBB4/PI3K/AKT axis.
    Wang S; Li Z; Zhu G; Hong L; Hu C; Wang K; Cui K; Hao C
    J Ovarian Res; 2021 Nov; 14(1):154. PubMed ID: 34774079
    [TBL] [Abstract][Full Text] [Related]  

  • 23. EZH2 activates CHK1 signaling to promote ovarian cancer chemoresistance by maintaining the properties of cancer stem cells.
    Wen Y; Hou Y; Yi X; Sun S; Guo J; He X; Li T; Cai J; Wang Z
    Theranostics; 2021; 11(4):1795-1813. PubMed ID: 33408782
    [No Abstract]   [Full Text] [Related]  

  • 24. Combined Poziotinib with Manidipine Treatment Suppresses Ovarian Cancer Stem-Cell Proliferation and Stemness.
    Lee H; Kim JW; Lee DS; Min SH
    Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33036254
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stemness and chemoresistance are imparted to the OC cells through TGFβ1 driven EMT.
    Mitra T; Prasad P; Mukherjee P; Chaudhuri SR; Chatterji U; Roy SS
    J Cell Biochem; 2018 Jul; 119(7):5775-5787. PubMed ID: 29537103
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibitory effects of metformin at low concentration on epithelial-mesenchymal transition of CD44(+)CD117(+) ovarian cancer stem cells.
    Zhang R; Zhang P; Wang H; Hou D; Li W; Xiao G; Li C
    Stem Cell Res Ther; 2015 Dec; 6():262. PubMed ID: 26718286
    [TBL] [Abstract][Full Text] [Related]  

  • 27. LINC01234 regulates microRNA-27b-5p to induce the migration, invasion and self-renewal of ovarian cancer stem cells through targeting SIRT5.
    Ke F; Ren C; Zhai Z; Gao X; Wei J; Zhu Y; Zhi Y
    Cell Cycle; 2022 May; 21(10):1020-1033. PubMed ID: 35230909
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ascites-derived ALDH+CD44+ tumour cell subsets endow stemness, metastasis and metabolic switch via PDK4-mediated STAT3/AKT/NF-κB/IL-8 signalling in ovarian cancer.
    Jiang YX; Siu MK; Wang JJ; Mo XT; Leung TH; Chan DW; Cheung AN; Ngan HY; Chan KK
    Br J Cancer; 2020 Jul; 123(2):275-287. PubMed ID: 32390009
    [TBL] [Abstract][Full Text] [Related]  

  • 29. S100B Mediates Stemness of Ovarian Cancer Stem-Like Cells Through Inhibiting p53.
    Yang T; Cheng J; Yang Y; Qi W; Zhao Y; Long H; Xie R; Zhu B
    Stem Cells; 2017 Feb; 35(2):325-336. PubMed ID: 27501952
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The NOP14 nucleolar protein suppresses the function and stemness of melanoma stem-like cells through Wnt/beta-catenin signaling inactivation.
    Li J; Fang R; Wu J; Si Y; Bai J; Wang Q
    Bioengineered; 2022 Mar; 13(3):7648-7658. PubMed ID: 35282769
    [TBL] [Abstract][Full Text] [Related]  

  • 31. LINC00115 promotes stemness and inhibits apoptosis of ovarian cancer stem cells by upregulating SOX9 and inhibiting the Wnt/β-catenin pathway through competitively binding to microRNA-30a.
    Hou R; Jiang L
    Cancer Cell Int; 2021 Jul; 21(1):360. PubMed ID: 34238293
    [TBL] [Abstract][Full Text] [Related]  

  • 32. DLL4 overexpression increases gastric cancer stem/progenitor cell self-renewal ability and correlates with poor clinical outcome via Notch-1 signaling pathway activation.
    Miao ZF; Xu H; Xu HM; Wang ZN; Zhao TT; Song YX; Xu YY
    Cancer Med; 2017 Jan; 6(1):245-257. PubMed ID: 27891816
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Autocrine interleukin-23 promotes self-renewal of CD133+ ovarian cancer stem-like cells.
    Wang D; Xiang T; Zhao Z; Lin K; Yin P; Jiang L; Liang Z; Zhu B
    Oncotarget; 2016 Nov; 7(46):76006-76020. PubMed ID: 27738346
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Notch1 signaling pathway promotes invasion, self-renewal and growth of glioma initiating cells via modulating chemokine system CXCL12/CXCR4.
    Yi L; Zhou X; Li T; Liu P; Hai L; Tong L; Ma H; Tao Z; Xie Y; Zhang C; Yu S; Yang X
    J Exp Clin Cancer Res; 2019 Aug; 38(1):339. PubMed ID: 31382985
    [TBL] [Abstract][Full Text] [Related]  

  • 35. FZD7 accelerates hepatic metastases in pancreatic cancer by strengthening EMT and stemness associated with TGF-β/SMAD3 signaling.
    Zhang Z; Xu Y
    Mol Med; 2022 Jul; 28(1):82. PubMed ID: 35854234
    [TBL] [Abstract][Full Text] [Related]  

  • 36. SNORA72 Activates the Notch1/c-Myc Pathway to Promote Stemness Transformation of Ovarian Cancer Cells.
    Zhang L; Ma R; Gao M; Zhao Y; Lv X; Zhu W; Han L; Su P; Fan Y; Yan Y; Zhao L; Ma H; Wei M; He M
    Front Cell Dev Biol; 2020; 8():583087. PubMed ID: 33224949
    [TBL] [Abstract][Full Text] [Related]  

  • 37. RECK inhibits stemness gene expression and tumorigenicity of gastric cancer cells by suppressing ADAM-mediated Notch1 activation.
    Hong KJ; Wu DC; Cheng KH; Chen LT; Hung WC
    J Cell Physiol; 2014 Feb; 229(2):191-201. PubMed ID: 23881612
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metformin anticancer: Reverses tumor hypoxia induced by bevacizumab and reduces the expression of cancer stem cell markers CD44/CD117 in human ovarian cancer SKOV3 cells.
    Fan Y; Cheng H; Liu Y; Liu S; Lowe S; Li Y; Bentley R; King B; Tuason JPW; Zhou Q; Sun C; Zhang H
    Front Pharmacol; 2022; 13():955984. PubMed ID: 36046821
    [No Abstract]   [Full Text] [Related]  

  • 39. MicroRNA-23a depletion promotes apoptosis of ovarian cancer stem cell and inhibits cell migration by targeting DLG2.
    Zhuang RJ; Bai XX; Liu W
    Cancer Biol Ther; 2019; 20(6):897-911. PubMed ID: 30862230
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MicroRNA‑455 inhibits cell proliferation and invasion of epithelial ovarian cancer by directly targeting Notch1.
    Xu L; Li H; Su L; Lu Q; Liu Z
    Mol Med Rep; 2017 Dec; 16(6):9777-9785. PubMed ID: 29039517
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.